These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 15200411

  • 1. Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease.
    Marchlewska A, Stenvinkel P, Lindholm B, Danielsson A, Pecoits-Filho R, Lönnqvist F, Schalling M, Heimbürger O, Nordfors L.
    Kidney Int; 2004 Jul; 66(1):46-50. PubMed ID: 15200411
    [Abstract] [Full Text] [Related]

  • 2. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin.
    Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimbürger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, Schalling M, Barany P, Lindholm B, Nordfors L.
    Kidney Int; 2004 Jan; 65(1):274-81. PubMed ID: 14675060
    [Abstract] [Full Text] [Related]

  • 3. Altered relationship between body fat and plasma adiponectin in end-stage renal disease.
    Shoji T, Shinohara K, Hatsuda S, Kimoto E, Fukumoto S, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y.
    Metabolism; 2005 Mar; 54(3):330-4. PubMed ID: 15736110
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy.
    Yao Q, Nordfors L, Axelsson J, Heimbürger O, Qureshi AR, Báràny P, Lindholm B, Lönnqvist F, Schalling M, Stenvinkel P.
    Atherosclerosis; 2005 Sep; 182(1):105-11. PubMed ID: 16115480
    [Abstract] [Full Text] [Related]

  • 5. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease.
    Roubicek T, Bartlova M, Krajickova J, Haluzikova D, Mraz M, Lacinova Z, Kudla M, Teplan V, Haluzik M.
    Nutrition; 2009 Sep; 25(7-8):762-8. PubMed ID: 19539174
    [Abstract] [Full Text] [Related]

  • 6. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.
    Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimbürger O, Holmes C, Schalling M, Nordfors L.
    Kidney Int; 2005 Jun; 67(6):2383-92. PubMed ID: 15882283
    [Abstract] [Full Text] [Related]

  • 7. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue.
    Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y, Brichard SM.
    Biochem Biophys Res Commun; 2001 Nov 16; 288(5):1102-7. PubMed ID: 11700024
    [Abstract] [Full Text] [Related]

  • 8. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
    Díez JJ, Iglesias P, Fernández-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, Codoceo R, Selgas R.
    Clin Endocrinol (Oxf); 2005 Feb 16; 62(2):242-9. PubMed ID: 15670203
    [Abstract] [Full Text] [Related]

  • 9. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.
    Suliman ME, Stenvinkel P, Bárány P, Heimbürger O, Anderstam B, Lindholm B.
    Am J Kidney Dis; 2003 Mar 16; 41(3 Suppl 1):S89-95. PubMed ID: 12612961
    [Abstract] [Full Text] [Related]

  • 10. Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients.
    Zoccali C, Tripepi G, Cambareri F, Catalano F, Finocchiaro P, Cutrupi S, Pizzini P, Testa A, Spoto B, Panuccio V, Enia G, Mallamaci F.
    J Ren Nutr; 2005 Jan 16; 15(1):125-30. PubMed ID: 15648021
    [Abstract] [Full Text] [Related]

  • 11. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B.
    Am J Kidney Dis; 2006 Jan 16; 47(1):139-48. PubMed ID: 16377395
    [Abstract] [Full Text] [Related]

  • 12. Epicardial adipose tissue and coronary artery calcification in diabetic and nondiabetic end-stage renal disease patients.
    Tonbul HZ, Turkmen K, Kayıkcıoglu H, Ozbek O, Kayrak M, Biyik Z.
    Ren Fail; 2011 Jan 16; 33(8):770-5. PubMed ID: 21770856
    [Abstract] [Full Text] [Related]

  • 13. Adiponectin gene expression in human primary adipocyte culture treated with uremic serum.
    Alouffi S, Howse M, Sharma A, Ranganath L.
    Saudi J Kidney Dis Transpl; 2015 Nov 16; 26(6):1190-8. PubMed ID: 26586058
    [Abstract] [Full Text] [Related]

  • 14. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
    Pawlaczyk K, Oko A, Lindholm B, Czekalski S.
    Pol Merkur Lekarski; 2003 Oct 16; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
    [Abstract] [Full Text] [Related]

  • 15. Low leptin gene expression and hyperleptinemia in chronic renal failure.
    Nordfors L, Lönnqvist F, Heimbürger O, Danielsson A, Schalling M, Stenvinkel P.
    Kidney Int; 1998 Oct 16; 54(4):1267-75. PubMed ID: 9767543
    [Abstract] [Full Text] [Related]

  • 16. Adiponectin and end-stage renal disease.
    Markaki A, Psylinakis E, Spyridaki A.
    Hormones (Athens); 2016 Jul 16; 15(3):345-354. PubMed ID: 27838604
    [Abstract] [Full Text] [Related]

  • 17. Adiponectin and cardiovascular remodeling in end-stage renal disease and co-morbid diabetes mellitus.
    Karakitsos D, De Groot E, Patrianakos AP, Parthenakis F, Boletis J, Karabinis A, Kyriazis J, Vardas P, Daphnis E.
    Am J Nephrol; 2006 Jul 16; 26(4):340-7. PubMed ID: 16825760
    [Abstract] [Full Text] [Related]

  • 18. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
    Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D.
    Nephrol Dial Transplant; 2005 Jan 16; 20(1):129-34. PubMed ID: 15585515
    [Abstract] [Full Text] [Related]

  • 19. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q, Pecoits-Filho R, Lindholm B, Stenvinkel P.
    Scand J Urol Nephrol; 2004 Jan 16; 38(5):405-16. PubMed ID: 15764253
    [Abstract] [Full Text] [Related]

  • 20. [Chronic inflammation and cardiovascular risk in hemodialysis].
    Pertosa G, Simone S, Soccio M, Marrone D, Grandaliano G.
    G Ital Nefrol; 2003 Jan 16; 20(6):631-40. PubMed ID: 14732917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.